Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10018509
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018509
Fusion event
HBV-CALR integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2017
PubMed ID
29212479
Virus Sequence
Virus name
HBV
Reference genome
NC_003977
Start
480
End
639
Integrated sequence
CTAATTCCAGGATCCTCAACAACCAGCACGGGACCATGCCGGACCTGCATGACTACTGCTCAAGGAACCTCTATGTATCCCTCCTGTTGCTGTACCAAACCTTCGGACGGAAATTGCACCTGTATTCCCATCCCATCATCCTGGGCTTTCGGAAAATTCC
Host Sequence
Chromosome
chr19
Cytoband
p13.13
Reference genome
GRCh37.55
Start
13054347/12943533 (Hg38)
End
13054443/12943629 (Hg38)
Location type
Exon8
Fragile sites / regions
FRA19B
Target gene
CALR
miRNAs that regulate target gene
hsa-mir-124-3p
;
hsa-mir-122-5p
;
hsa-mir-1-3p
;
hsa-mir-16-5p
;
hsa-mir-423-3p
;
hsa-mir-320a
;
hsa-mir-149-5p
;
hsa-mir-148a-5p
;
hsa-mir-516a-5p
;
hsa-mir-875-3p
;
hsa-mir-1254
;
hsa-mir-3116
;
hsa-mir-3148
;
hsa-mir-3646
;
hsa-mir-3662
;
hsa-mir-6849-3p
;
hsa-mir-6782-5p
;
hsa-mir-412-3p
;
hsa-mir-6783-3p
;
hsa-mir-1343-3p
;
hsa-mir-6848-5p
;
hsa-mir-6846-5p
;
hsa-mir-4697-5p
;
hsa-mir-4488
;
hsa-mir-1237-5p
;
hsa-mir-486-3p
;
hsa-mir-6721-5p
;
hsa-mir-6878-5p
;
hsa-mir-4763-3p
;
hsa-mir-1207-5p
;
hsa-mir-6722-3p
;
hsa-mir-1909-3p
;
hsa-mir-6738-5p
;
hsa-mir-5194
;
hsa-mir-1914-3p
;
hsa-mir-1225-3p
;
hsa-mir-1253
;
hsa-mir-3179
;
hsa-mir-203a-3p
;
hsa-mir-5681a
;
hsa-mir-6742-3p
;
hsa-mir-637
;
hsa-mir-6852-5p
;
hsa-mir-939-3p
;
hsa-mir-1910-5p
;
hsa-mir-6838-3p
;
hsa-mir-4756-5p
;
hsa-mir-4739
;
hsa-mir-1321
;
hsa-mir-5197-3p
;
hsa-mir-1252-3p
;
hsa-mir-4533
;
hsa-mir-4518
;
hsa-mir-4468
;
hsa-mir-1266-5p
;
hsa-mir-3664-3p
;
hsa-mir-1245b-3p
;
hsa-mir-6876-5p
;
hsa-mir-4476
;
hsa-mir-2278
;
hsa-mir-4428
;
hsa-mir-665
;
hsa-mir-216a-5p
;
hsa-mir-4534
;
hsa-mir-4665-5p
;
hsa-mir-1275
;
hsa-mir-4472
;
hsa-mir-7847-3p
;
hsa-mir-4447
;
hsa-mir-92a-2-5p
;
hsa-mir-6766-5p
;
hsa-mir-6756-5p
;
hsa-mir-608
;
hsa-mir-4651
;
hsa-mir-7110-5p
;
hsa-mir-6842-5p
;
hsa-mir-6752-5p
;
hsa-mir-5010-5p
;
hsa-mir-4525
;
hsa-mir-6870-5p
;
hsa-mir-7111-5p
;
hsa-mir-5698
;
hsa-mir-4723-5p
;
hsa-mir-625-5p
;
hsa-mir-6825-5p
;
hsa-mir-3175
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-8085
;
hsa-mir-6787-5p
;
hsa-mir-6731-5p
;
hsa-mir-663a
;
hsa-mir-1908-5p
;
hsa-mir-6894-5p
;
hsa-mir-765
;
hsa-mir-7154-3p
;
hsa-mir-766-5p
;
hsa-mir-5192
;
hsa-mir-4749-5p
;
hsa-mir-4706
;
hsa-mir-4693-3p
;
hsa-mir-6889-5p
;
hsa-mir-6777-5p
;
hsa-mir-6732-5p
;
hsa-mir-6783-5p
;
hsa-mir-4779
;
hsa-mir-3141
;
hsa-mir-6124
;
hsa-mir-342-3p
;
hsa-mir-6716-3p
;
hsa-mir-6771-3p
Nearest miRNA
hsa-mir-10395/Upstream/2993; hsa-let-7e/Downstream/892658;
Nearest TSS
ENST00000633603/Upstream/320;
ENST00000586967/Downstream/244;
Nearest CpG islands
None/Target,
chr19-CpG: 112/Upstream/4538
,
chr19-CpG: 69/Downstream/2015
Upstream sequence
CAAAGAAGCATTTGTGGAGCACCTTCTGTGTGCCCCTAGGTACTAGATGCCTGGACGGGGTCAGAAGGACCCTGACCCACCTTGAACTTGTTCCACACAG
Downstream sequence
GTGAGGCCTGGTCCTGGTCCTGATGTCGGGGGCGGGCAGGGCTGGCAGGGGGCAAGGCCCTGAGGTGTGTGCTCTGCCTGCAGGCAGCAGAGAAACAAAT
Target sequence
CAGGTCAAGTCTGGCACCATCTTTGACAACTTCCTCATCACCAACGATGAGGCATACGCTGAGGAGTTTGGCAACGAGACGTGGGGCGTAACAAAG
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Sample Information
×
Sample name
P157A
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate